強生以34億美元收購Auris,加速進入機器人領域
@汇众医疗:
Auris Health 是一家致力於肺癌的機器人技術開發商。本次收購預計於2019年第二季度末完成,在之前,強生於去年收購了 Orthotaxy——一傢俬人控股的外科手術軟件技術開發商。 $強生(JNJ)$ $直覺外科公司(ISRG)$ #機器人# Feb 13 (Reuters) - Johnson & Johnson is buying privately held surgical robotics company Auris Health Inc for about $3.4 billion in cash, the healthcare conglomerate said on Wednesday, as it continues its push into robotics. 路透2月13日電---強生週三表示,隨着其繼續進軍機器人領域,將以約34億美元現金收購私有外科機器人公司 Auris Health Inc。 The agreement includes additional payments by J&J of $2.35 billion, contingent upon Auris reaching certain milestones, J&J said, without elaborating. 強生表示,該協議包括強生支付的23.5億美元額外款項,前提是 Auris 達到了某些里程碑。 Auris Health is a developer of robotic technologies focused on lung cancer. The deal follows J&J's acquisition last year of Orthotaxy, a privately held developer of